| Similar Articles |
|---|
 |
The Motley Fool
January 11, 2007
Matt Koppenheffer |
The 5-Sigma Report A look at the stocks that saw serious volatility last week. Semiconductor Manufacturing International... Herbalife... New York & Company... Atherogenics... Hot Topic...   |
The Motley Fool
January 24, 2007
Matt Koppenheffer |
The 5-Sigma Report These stocks experienced serious volatility in the past week: Mills... Rackable Systems... Genesis HealthCare... GPC Biotech... Total System Services... |
The Motley Fool
December 27, 2006
Brian Lawler |
Telik Falls Short Shares of another biopharma fall after disappointing clinical trial results. |
The Motley Fool
December 19, 2006
Matt Koppenheffer |
The 5-Sigma Report A look at the stocks that saw serious volatility last week. Nuvelo... Hubbell... EPIX Pharmaceuticals... Spartech... Companhia de Saneamento Basico do Estado de Sao Paulo... etc. |
The Motley Fool
January 31, 2007
Matt Koppenheffer |
The 5-Sigma Report A look at the stocks that experienced serious volatility last week. 21st Century Insurance Group... LECG... Novelis... National Interstate Group... Technitrol... |
The Motley Fool
October 15, 2007
Brian Lawler |
A Surprising Decision for Telik It still doesn't look like the pharma's lead drug is helping anyone get better. Investors, take note. |
The Motley Fool
February 27, 2007
Brian Lawler |
Three Strikes for Telik Investors, there's not much in the pipeline at this small biotech company. |
The Motley Fool
June 6, 2007
Brian Lawler |
Is Telik Insane? Shares of Telik fall after the FDA puts a halt to trials with its lead drug. Even at this reduced share price, investors should stay far away from this pharma. |
The Motley Fool
December 12, 2006
Matt Koppenheffer |
The 5-Sigma Report A look at the stocks that saw serious volatility last week. Gallaher Group... Kyphon... Vanda Pharmaceuticals... Bank of New York... Pfizer... |
The Motley Fool
November 29, 2006
Matt Koppenheffer |
The 5-Sigma Report In a 5-sigma move, a stock has a one-day price move that is five standard deviations or more from the stock's average one-day change. Here are more stocks that defy the averages. Blockbuster... J Crew Group... etc. |
The Motley Fool
December 5, 2006
Matt Koppenheffer |
The 5-Sigma Report What caused the biggest moves of the week? Abington Community Bancorp... Dress Barn... Dynavax Technologies... DSW... |
The Motley Fool
March 20, 2007
Matt Koppenheffer |
The 5-Sigma Report A look at the stocks that saw serious volatility last week. Accredited Home Lenders... Newcastle Investment... NovaStar Financial... Fremont General... American Oriental Bioengineering... |
BusinessWeek
February 9, 2004
Gene G. Marcial |
Telik's Promising Tumor Treatments Telik, which develops drugs for cancer -- mainly chemotherapy-resistant solid tumors -- and diabetes may be the next biotech buyout. So says Mark Monane of investment outfit Needham, who identified Esperion Therapeutics in early December as buyout bait. |
The Motley Fool
April 23, 2007
Matt Koppenheffer |
The 5-Sigma Report A look at the stocks that saw serious volatility last week. Spansion... Briggs & Stratton... Solarfun Power Holdings... Labor Ready... etc. |
The Motley Fool
February 15, 2007
Matt Koppenheffer |
The 5-Sigma Report A look at the stocks that saw serious volatility last week: Nxstage Medical ... New Century Financial... Domino's Pizza... TeleTech Holdings... Omniture... |
The Motley Fool
September 26, 2007
Brian Lawler |
Following the Fallen Biotech Class of 2006 Let's take a look a list of the biggest development stage drugmaker disasters from 2006 and how the tiny drug developers have fared since they announced their clinical trial or regulatory failures. |
The Motley Fool
November 14, 2006
Matt Koppenheffer |
5-Sigma II: The Aftermath Investors, the bottom line is that you need to get past a stock's price movement and figure out what caused it before you can make any decision based on that movement. |
